Sr One Capital Management »

Ultragenyx Pharmaceutical shares owned by Sr One Capital Management

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Sr One Capital Management from 13F filings

Historical chart of Sr One Capital Management investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Sr One Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Sr One Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.2M 138k 23.00

More positions owned by Sr One Capital Management

Zenas BioPharma Common Stock (ZBIO)
Arcellx Common Stock (ACLX)
CRISPR Therapeutics Common Shares (CRSP)
Design Therapeutics Common Stock (DSGN)
Mineralys Therapeutics Common Stock (MLYS)
ARS Pharmaceuticals Common Stock (SPRY)
ORIC Pharmaceuticals Common Stock (ORIC)
Alumis Common Stock (ALMS)
Oruka Therapeutics Common Stock (ORKA)
Oculis Holding Ordinary Shares (OCS)
enGene Holdings Common Shares (ENGN)
Nkarta Common Stock (NKTX)
Ultragenyx Pharmaceutical Common Stock (RARE)

View all positions for Sr One Capital Management

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
FMR
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Sands Capital Management
Rtw Investments
Baker Bros. Advisors
Suvretta Capital Management
Frontier Capital Management
Wellington Management Company
Bnp Paribas Investment Partners
Geode Capital Management
Jacobs Levy Equity Management
Standard Life Aberdeen

View all funds holding Ultragenyx Pharmaceutical